Aristeia Capital’s Envoy Medical Warrant COCHW Stock Holding History

Aristeia Capital’s Portfolio COCHW Stock Details COCHW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$79.3K	Hold	1,143,978	–	–	﹤0.01%	542
2025 Q4	$49.5K	Buy	1,143,978 +83,056	+8%	+$3.86K	﹤0.01%	510
2025 Q3	$39.9K	Hold	1,060,922	–	–	﹤0.01%	466
2025 Q2	$45.6K	Hold	1,060,922	–	–	﹤0.01%	425
2025 Q1	$32.7K	Sell	1,060,922 -24,989	-2%	-$980	﹤0.01%	375
2024 Q4	$41.5K	Hold	1,085,911	–	–	﹤0.01%	322
2024 Q3	$86.3K	Hold	1,085,911	–	–	﹤0.01%	258
2024 Q2	$64.1K	Sell	1,085,911 -400	-0%	-$44	﹤0.01%	242
2024 Q1	$116K	Sell	1,086,311 -3,578	-0.3%	-$240	﹤0.01%	183
2023 Q4	$25.6K	Hold	1,089,889	–	–	﹤0.01%	131
2023 Q3	$89.8K	Hold	1,089,889	–	–	﹤0.01%	119
2023 Q2	$50.9K	Buy	1,089,889 +199,247	+22%	+$10K	﹤0.01%	158
2023 Q1	$31.4K	Hold	890,642	–	–	﹤0.01%	283
2022 Q4	$35K	Hold	890,642	–	–	﹤0.01%	378
2022 Q3	$52K	Hold	890,642	–	–	﹤0.01%	469
2022 Q2	$95K	Hold	890,642	–	–	﹤0.01%	431
2022 Q1	$212K	Hold	890,642	–	–	﹤0.01%	450
2021 Q4	$695K	Buy	+890,642	New	+$652K	0.01%	420

Other funds holding COCHW

OMC

Oasis Management Company Grand Cayman, Cayman Islands $1.72B AUM 32.1% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.02% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.25% 1-Year Est. Return

Athos Capital Hong Kong $324M AUM 16.62% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

BCL

Bracebridge Capital LLC Boston, Massachusetts $3.73B AUM 33.02% 1-Year Est. Return

SummitTX Capital Fort Worth, Texas $3.2B AUM 41.22% 1-Year Est. Return

Diametric Capital Boston, Massachusetts $385M AUM 31.7% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Aristeia Capital's COCHW Position: Q1 2026 in Review

Aristeia Capital held its Envoy Medical Warrant (COCHW) position steady in Q1 2026 at 1,143,978 shares worth $79.3K. The position accounts for ﹤0.01% of the portfolio, ranked #542.

Aristeia Capital first reported a position in COCHW in Q4 2021 and has held it in 18 quarters since. The position peaked at $695K in Q4 2021. 34 funds tracked by Wall St. Rank hold COCHW as of Q1 2026.

Aristeia Capital held 1,143,978 shares of Envoy Medical Warrant worth $79.3K as of Q1 2026.
Aristeia Capital left its Envoy Medical Warrant share count unchanged in Q1 2026.
Envoy Medical Warrant made up ﹤0.01% of Aristeia Capital's portfolio in Q1 2026, its #542 holding.
Aristeia Capital first reported a position in Envoy Medical Warrant in Q4 2021 and has held it in 18 quarters since.
Aristeia Capital's Envoy Medical Warrant position peaked at $695K in Q4 2021.
34 funds tracked by Wall St. Rank held Envoy Medical Warrant as of Q1 2026.

Based on Aristeia Capital's 13F filing for Q1 2026, filed 15 May 2026.